Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

Caution must be taken when trying to transfer conclusions of pharmacoeconomics studies on migraines even in neighbouring countries. This cross-country variability is a concern for decision-makers and also for the elaboration of international recommendations and clinical practice guidelines. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014

MoreLess

Year of publication:	2014
Authors:	Hens, Manuel ; Villaverde-Hueso, Ana ; Alonso, Veronica ; Abaitua, Ignacio ; Paz, Manuel Posada de la
Published in:	The European Journal of Health Economics. - Springer. - Vol. 15.2014, 4, p. 433-437
Publisher:	Springer
Subject:	Migraine \| Therapy \| Triptans \| Cost-effectiveness \| Health economics \| Treatment

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993868